Pain. Pain, unspecified
Conditions
Interventions
Intervention 1: The first intervention group (i.e., The Ketorolac group): Having undergone general anesthesia, they will get injected by Ketorolac (30 mg for those 50 kg). After 4 hours, Faces Pain Sc
Treatment - Drugs
The first intervention group (i.e., The Ketorolac group): Having undergone general anesthesia, they will get injected by Ketorolac (30 mg for those 50 kg). After 4 hours, Faces Pain Scale and Visual A
The second intervention group (i.e., The Pethadine group): Having undergone general anesthesia, they will get injected by Pethidine (30 mg). After 4 hours, Faces Pain Scale and Visual Analog Scale wil
Sponsors
Vice-chancellery for Reasearch at Birjand University of Medicla Sciences
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Inclusion criteria: Candidates for elective caesarean section willing to participate; lack of dependency on opioids, atopy and bronchial asthma, diabetes, renal and hepatic disease, alcohol or drugs abuse, gestational hypertension, preeclampsia and peptic ulcer disease, multiple pregnancy, obesity, infant macrosomia; exclusion criteria: unwillingness to continue participation.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain intensity. Timepoint: 4 hours after treatment. Method of measurement: Faces Pain Scale and Visual Analog Scale (VAS).;Anelgesic duration. Timepoint: From end of intervention until first pain onset. Method of measurement: patient self-report. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZainab Abbaspour Benhangi
Birjand Univercity of Medical Sciences
Outcome results
None listed